Wearable sensor feedback may motivate cancer survivors to exercise more

NCT ID NCT05490641

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether showing cancer survivors real-time glucose data from a wearable sensor can encourage them to be more physically active. 60 cancer survivors at high risk for type 2 diabetes wore a Fitbit and some also wore a continuous glucose monitor for 4 weeks, receiving personalized text messages. The goal was to see if this approach is feasible and if it increases daily activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Glucose-based biofeedback via continuous glucose monitor and Fitbit activity tracker
What this could lead to
If it works, this could point toward a simple, low-cost way to help cancer survivors become more active and reduce their diabetes risk.
What could go wrong
This is a small, early feasibility study with only 60 participants. It tests whether the approach is practical, not whether it improves health outcomes. Results may not apply to all cancer survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas at Arlington

    Arlington, Texas, 76010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.